Barclays sees four key catalysts ahead for this 'overlooked' investment opportunity

  • 📰 CNBC
  • ⏱ Reading Time:
  • 21 sec. here
  • 18 min. at publisher
  • 📊 Quality Score:
  • News: 68%
  • Publisher: 72%

In Vitro Fertilization News

Health Insurance,Biotech And Pharmaceuticals,Stock Markets

Barclays sees an improvement in the investment narrative for fertility stocks. These are names on its buy list.

There are a number of catalysts ahead for fertility stocks and many investors may be missing out, according to Barclays. The bank recently analyzed stocks tied to the theme and spoke with investors about it. "Our conversations with investors suggest that the fertility theme has been rather overlooked so far," analyst Laia Marin wrote in a note last week, the second part of a two-part look at fertility stocks.

mountain Progyny one-year performance Barclays sees four key catalysts for the group. For one, there are broader fertility policy approaches emerging around the globe, Marin said. Specifically, policies in countries where the population has already peaked — such as Europe, China and Japan — could play a key role in bringing fertility rates back to replacement levels of 2.1 births per woman.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

'Rate cut winners': Barclays names global stocks to buy when interest rates are cutThe investment bank also named two sectors that are likely to behave in a contrarian manner.
Source: CNBC - 🏆 12. / 72 Read more »

Nvidia earnings the next key catalyst for Big Tech: BarclaysNvidia earnings the next key catalyst for Big Tech: Barclays
Source: Investingcom - 🏆 450. / 53 Read more »